← Back

$ Value

Shares

3,190

Price

Filed

Mar 2

Insider

Name

McMillan Wayde D.

Title

CIK

0001768648

Roles

Director

Transaction Details

Transaction Date

2026-02-26

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,932

Footnotes

Represents restricted stock units which vest on the date of the 2027 Annual Meeting of Stockholders and are settled in shares of common stock. | Restricted stock units are settled in shares of common stock on a one-for-one basis.

Filing Info

Accession No.

0000859737-26-000023

Form Type

4

Issuer CIK

0000859737

McMillan Wayde D.'s History

Date Ticker Type Value
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-03-06 SOLV M $0
2026-03-06 SOLV F $193K
2026-03-06 SOLV M $0
2026-03-05 SOLV A $0
2026-02-26 HOLX A
2025-12-01 SOLV M
2025-12-01 SOLV F $1.1M
2025-12-01 SOLV M $0

Other Insiders at HOLX (90d)

Insider Bought Sold Last
MACMILLAN STEPHEN P
Chairman, President and CEO
2026-04-07
Madaus Martin D 2026-04-07
Oberton Karleen Marie
Chief Financial Officer
2026-04-07
Dockendorff Charles J 2026-04-07
Wendell Amy McBride 2026-04-07
Stewart Stacey D. 2026-04-07
HANTSON LUDWIG 2026-04-07
Stamoulis Christiana 2026-04-07
COHN BENJAMIN JORDAN
Principal Accounting Officer
2026-04-07
McMillan Wayde D. 2026-04-07
Verstreken Jan
Group President, International
2026-04-07
Mitchell Essex D
Chief Operating Officer
2026-04-07
Schneiders Jennifer M
President, Diag. Solutions
2026-04-07
Mohtashami Nanaz 2026-04-07
Schnittker Brandon
President, GYN Surgical
2026-04-07
De Walt Diana
SVP, Human Resources
2026-04-07
Horvath Mark W.
President, Breast & Skeletal
2026-04-07
Liddy Anne M.
General Counsel
2026-04-07